- Companies
- SI-BONE
SI-BONE Valuation Multiples
SI-BONE is valued at $1B as of November 2026, a 4.1x revenue multiple. In the last 12 months, SI-BONE revenue was $228M and SI-BONE EBITDA was $14M.
SI-BONE Overview
About SI-BONE
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Founded
2008
HQ
Employees
559
Website
Financials (LTM)
EV
$941M
Valuation Multiples
Start free trialSI-BONE Financials
SI-BONE reported last 12-month revenue of $228M and EBITDA of $14M.
In the same LTM period, SI-BONE generated $181M in gross profit, $14M in EBITDA, and had net loss of ($16M).
Revenue (LTM)
SI-BONE P&L
In the most recent fiscal year, SI-BONE reported revenue of $201M and EBITDA of ($17M).
SI-BONE is unprofitable as of last fiscal year, with gross margin of 80%, EBITDA margin of (8%), and net margin of (9%).
Financial data powered by Morningstar, Inc.
SI-BONE Stock Performance
SI-BONE has current market cap of $1B, and enterprise value of $941M.
Market Cap Evolution
SI-BONE's stock price is $23.15.
SI-BONE share price increased by 9.0% in the last 30 days, and by 19.0% in the last year.
SI-BONE has an EPS (earnings per share) of $-0.42.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $941M | $1B | -1.1% | 9.0% | 21.7% | 19.0% | $-0.42 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSI-BONE Valuation Multiples
SI-BONE trades at 4.1x EV/Revenue multiple, and 69.3x EV/EBITDA.
EV / Revenue (LTM)
SI-BONE Financial Valuation Multiples
As of November 18, 2026, SI-BONE has market cap of $1B and EV of $941M.
SI-BONE has a P/E ratio of (67.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SI-BONE Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SI-BONE Margins & Growth Rates
SI-BONE grew revenue by 16% but EBITDA decreased by 186% in the last fiscal year.
In the most recent fiscal year, SI-BONE reported gross margin of 80%, EBITDA margin of (8%), and net margin of (9%).
SI-BONE Margins
SI-BONE Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SI-BONE Operational KPIs
SI-BONE's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
SI-BONE's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SI-BONE's Rule of X is 45% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
SI-BONE Competitors
SI-BONE competitors include PHC Holdings, Integra Lifesciences, Wandong Medical, AdaptHealth, MedicalSystem Technology, Alphatec Holdings, iRadimed, CeriBell, Shinva and Alpha Tau Medical.
Most SI-BONE public comparables operate across Medical Devices, DeepTech and HealthTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $2.3B | $312M | 0.9x | 0.9x | 6.9x | 5.8x | |||
| $1.6B | ($344M) | 0.6x | 0.6x | (3.1x) | 3.3x | |||
| $202M | ($46M) | 3.2x | 2.8x | (13.9x) | - | |||
| $3.2B | $473M | 0.9x | 1.0x | 6.4x | 5.7x | |||
| $45M | $12M | 21.9x | 17.3x | 81.8x | 67.1x | |||
| $764M | ($15M) | 2.1x | 1.9x | (107.5x) | 12.2x | |||
| $84M | $28M | 12.0x | 11.0x | 36.5x | 30.8x | |||
| $89M | ($50M) | 10.3x | 8.1x | (18.2x) | (17.2x) | |||
This data is available for Pro users. Sign up to see all SI-BONE competitors and their valuation data. Start Free Trial | ||||||||
SI-BONE VC Funding History
Before going public, SI-BONE raised $80M in total equity funding, across 3 rounds.
SI-BONE Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SI-BONE
| Who are competitors of SI-BONE? | SI-BONE main competitors include PHC Holdings, Integra Lifesciences, Wandong Medical, AdaptHealth, MedicalSystem Technology, Alphatec Holdings, iRadimed, CeriBell, Shinva, Alpha Tau Medical. |
See public comps similar to SI-BONE
Lists including SI-BONE
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




